Sponsored Research
Adam Devore of Cardiology has received an award (1UG3-HL173571-01) from the National Institutes of Health for a project entitled "1/2 Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction Extension Trial." Total funding will be $877,758.
Marat Fudim of Cardiology has received an award (1R01-HL171305-01) from the National Institutes of Health for a project entitled "Splanchnic Nerve Modulation In Heart Failure (Splanchnic X)." Total funding will be $2,533,785.
Svati Shah of Cardiology has received an award (1R01-HL168940-01A1) from the National Institutes of Health for a project entitled "Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders." Total funding will be $2,706,567.
Fahmin Basher (Mentor: Stefanie Sarantopoulos) of Cell Therapy has received an award from the Leukemia & Lymphoma Society for a project entitled "The Role of the DNA Sensor AIM2 in B Cell Fate and Function After HCT." Total funding will be $210,000.
Stefanie Sarantopoulos of Cell Therapy has received an award from the Leukemia & Lymphoma Society for a project entitled "Breaking B Cell Tolerance to Produce Novel CAR-T's." Total funding will be $210,000.
Jie Wang of Cell Therapy has received an award from the University of Virginia - Charlottesville for a project entitled "A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin versus Investigators Choice in Patients with Relapse or Refractory Peripheral T-cell Lymphoma (PTCL) PTCL-001." Total funding will be $10,000.
Jie Wang of Cell Therapy has received a sub-award (R01-FD006814-02) through the University of Virginia - Charlottesville for a project entitled "A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin versus Investigator's Choice in Patients with Relapse or Refractory Peripheral T-cell Lymphoma (PTCL) PTCL-001." Total funding will be $1.
Bryan Batch of Endocrinology has received an award (NIH DEIA Prize) from the National Institutes of Health for a project entitled "NIH DEIA Prize." Total funding will be $100,000.
Deborah Muoio of Endocrinology has received an award (2R01-DK089312-13) from the National Institutes of Health for a project entitled "Mechanisms of lipid-induced bioenergetic stress in muscle." Total funding will be $2,530,748.
Katherine Garman of Gastroenterology has received a sub-award (1P01-CA269019-01A1) through the Case Western Reserve University for a project entitled "Project 3: EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia." Total funding will be $82,270.
Jatin Roper of Gastroenterology has received an award (1U01-AI183940-01) from the National Institutes of Health for a project entitled "Sex differences in delayed development of gastrointestinal fibrosis after acute radiation exposure." Total funding will be $1,671,029.
Myles Wolf of Nephrology has received an award (2UH3-DK118748-06) from the National Institutes of Health for a project entitled """HiLo"": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis." Total funding will be $450,000.
Jason Somarelli of Oncology has received a sub-award () through the East Carolina University for a project entitled "Mitochondrial bioenergetics and colorectal cancer." Total funding will be $64,825.
Industry-Sponsored Clinical Trials
Marat Fudim of Cardiology has received an award from Tenax Therapeutics, Inc. for a project entitled "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction(PH-HFpEF); LEVEL:LEVosimendan to Improve Exercise Limitation in Pa." Total funding will be $488,289.
Neha Pagidipati of Cardiology has received an award from Bayer HealthCare Pharmaceuticals, Inc for a project entitled "Bayer AG - CKD Implementation -Multi-funded." Total funding will be $2,354,263.
Jennifer Rymer of Cardiology has received an award from Abiomed, Inc. for a project entitled "Protect IV." Total funding will be $446,788.
Lindsay Rein of Cell Therapy has received an award from Telios Pharma, Inc. for a project entitled "A Phase 2 Multicenter Study of TL-895 in Subjects with Relapsed/Refractory Myelofibrosis, Janus Kinase Inhibitor Intolerant Myelofibrosis, Janus Kinase Inhibitor Treatment Ineligible Myelofibrosis, or Indolent Systemic Mastocytosis." Total funding will be $217,021.
Daniel George of Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Phase 2, Randomized, Double-blind, Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Participants With Renal Cell Carcinoma." Total funding will be $678,053.
Juneko Grilley Olson of Oncology has received an award from Polaris Pharmaceuticals, Inc. for a project entitled "POLARIS 2022-001: ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects with Leiomyosarcoma (ARGSARC): A Randomized, Double-Blind, Multi-Center Phase 3 Trial." Total funding will be $685,214.
Yuh Chin Huang of Pulmonary has received an award from Chiesi Farmaceutici S.p.A. for a project entitled "TRITON A phase III, 52-week, multinational, multicenter, randomized, double-blind, 2-arm parallel group study comparing efficacy, safety and tolerability of the fixed dose triple combination of beclomethasone dipropionate plus formoterol fumarate." Total funding will be $989,966.
Lake Morrison of Pulmonary has received an award from United Therapeutics Corporation for a project entitled "TETON-PPF - A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)." Total funding will be $123,053.